Joaquin Duato is the Chief Executive Officer of Johnson & Johnson and serves on its Board of Directors. As CEO of the world’s largest healthcare company, Joaquin leads a global workforce of 135,000 employees in developing and delivering transformational and innovative healthcare solutions in Pharmaceuticals, MedTech, and Consumer Health.
From his early days in Spain, Joaquin found inspiration by focusing on how healthcare improved patients’ lives. Over the course of three decades with the company, he developed a deep understanding of what’s possible at Johnson & Johnson by working in all business sectors and across multiple geographies and functions. Before being named CEO, Joaquin served as the Vice Chairman of the Executive Committee, where he provided strategic direction for the Pharmaceutical and Consumer Health sectors and oversaw both Information Technology and the Global Supply Chain.
Joaquin’s many accomplishments include driving the transformation of the company’s pharmaceutical business into a global powerhouse by refocusing strategy and investment around core therapeutic areas and areas of greatest unmet need during his tenure as the sector’s Worldwide Chairman. More recently, he oversaw the company’s rapid response to the COVID-19 pandemic and drove coordination of global initiatives to safeguard the health of employees and ensure business and supply chain continuity, so the company’s life-saving medicines and products reached patients and communities in need.
A believer in the power of technology to accelerate progress in healthcare, Joaquin is leading Johnson & Johnson to harness data science and intelligent automation for insight generation so that teams work as a united front, with expertise and purpose, to solve the world’s toughest health challenges.
A dual citizen of Spain and the United States, Joaquin’s international perspective gives him a deep appreciation of diversity in all its forms. He is committed to building an inclusive workforce that reflects the patients J&J serves, evidenced by nearly a decade acting as Executive Sponsor for the African Ancestry Leadership Council ERG.
Joaquin earned an MBA from ESADE in Barcelona, Spain, and a Master of International Management from Thunderbird School of Global Management in Phoenix, Arizona. He lives in Pennsylvania with his wife and two college-aged children.
How old is Joaquin Duato?
Mr. Duato is currently 61 years old. There are 5 older executives and no younger executives at Johnson & Johnson. The oldest executive at Johnson & Johnson is Dr. John C. Reed M.D., Ph.D., Executive Vice President of Innovative Medicine, R&D, who is 66 years old. Learn More on Joaquin Duato's age.
How do I contact Joaquin Duato?
The corporate mailing address for Mr. Duato and other Johnson & Johnson executives is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. Johnson & Johnson can also be reached via phone at (732) 524-0400 and via email at investor-relations@its.jnj.com. Learn More on Joaquin Duato's contact information.
Has Joaquin Duato been buying or selling shares of Johnson & Johnson?
Who are Johnson & Johnson's active insiders?
Johnson & Johnson's insider roster includes Dominic Caruso (VP), Robert Decker (CAO), Joaquin Duato (CEO & Chairman), Peter Fasolo (VP), Alex Gorsky (CEO), William Hait (Insider), Ronald Kapusta (CAO), Ashley McEvoy (EVP), Thibaut Mongon (VP), William Perez (Director), Timothy Schmid (EVP, Worldwide Chairman, MedTech), Michael Sneed (COO), Paulus Stoffels (VP), James Swanson (EVP), Jennifer Taubert (EVP), Mark Weinberger (Director), Kathryn Wengel (EVP), Joseph Wolk (CFO), and Joseph Wolk (Exec. VP & CFO ). Learn More on Johnson & Johnson's active insiders.
Are insiders buying or selling shares of Johnson & Johnson?
During the last year, Johnson & Johnson insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $147,220.00. During the last year, insiders at the sold shares 2 times. They sold a total of 6,038 shares worth more than $993,041.55. The most recent insider tranaction occured on February, 18th when EVP Timothy Schmid sold 403 shares worth more than $62,928.45. Insiders at Johnson & Johnson own 0.2% of the company.
Learn More about insider trades at Johnson & Johnson. Information on this page was last updated on 2/18/2025.